Exhibit 99.1
FOR IMMEDIATE RELEASE
CONTACTS:
Cutera, Inc.
Ron Santilli
Chief Financial Officer
415-657-5500
Investor Relations
John Mills
Integrated Corporate Relations, Inc.
310-395-2215
jmills@icrinc.com
CUTERA® REPORTS THIRD QUARTER 2005 RESULTS
—Company Sets New Records for Revenue and Profitability, and Raises Guidance—
Brisbane, California, November 1, 2005 – Cutera, Inc.(Nasdaq: CUTR), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today reported financial results for the third fiscal quarter ended September 30, 2005.
Key financial highlights for third quarter 2005, compared with third quarter 2004, are as follows:
• | Revenue increased by 49% from $12.7 million to $19.0 million |
• | Operating margins improved from 9% to 25% |
• | Earnings per diluted share climbed from $0.07 to $0.27 |
• | Cash generated by operations improved from $2.8 million to $6.3 million |
Third quarter 2005 revenue was $19.0 million, representing a 49% increase from $12.7 million in revenue recorded in the third quarter of 2004. Net income for the third quarter of 2005 was $3.8 million, or $0.27 per diluted share, compared to net income of $877,000, or $0.07 per diluted share, reported in the same period last year. Cash generated by operations in the third quarter of 2005 was $6.3 million, compared with cash from operations of $2.8 million generated in the third quarter of 2004.
The Company’s revenue for the nine months ended September 30, 2005 was $51.7 million, a 41% increase from $36.5 million in revenue recorded in the same period last year. Net income for the first nine months of 2005 was $8.0 million, or $0.58 per diluted share, compared to net income of $1.7 million, or $0.14 per diluted share, reported in the same period last year. Cash generated by operations in the first nine months of 2005 was $12.8 million, compared with cash from operations of $5.3 million generated in the first nine months of 2004.
Kevin Connors, Cutera’s President and Chief Executive Officer, said, “We are pleased with our strong revenue growth, which we believe is outpacing the healthy growth in our sector. We are also experiencing significantly improved profitability due to the leveraging of our business model. Demand for our multi- application CoolGlide Xeo system, the Titan application, and the Solera platform, remains strong as customers continue to acquire our systems and upgrades to address the increasing consumer demand for non-invasive aesthetic procedures.
We remain committed to aggressively investing in our business to help us continue outpacing our industry’s rapid growth rate. Specifically, we are focused on the following key initiatives, which are yielding measurable returns as proven by our third quarter results: (i) worldwide sales force expansion; (ii) new aesthetic applications and product introductions; and, (iii) marketing to the broad and expanding market of physicians outside of the traditional dermatology and plastic surgery physician specialties, including the emerging medi-spa market. The medi-spa market is comprised of physicians who offer aesthetic treatments in a spa environment.”
Mr. Connors concluded, “In addition to the significant achievements of growing revenue and improved profitability, our balance sheet strengthened further in the third quarter of 2005, as we generated $6.3 million of cash from operations and ended that quarter with $82.2 million in cash and marketable securities- with no debt. This strong financial position, together with the fast paced growth of our Company, strategically positions Cutera as a leading global provider of light-based aesthetic systems.”
Guidance
Management believes that for the fourth quarter of 2005, revenue will be approximately $22.0 million with earnings per diluted share of approximately $0.29. For full year 2005, management is raising revenue guidance to approximately $73.6 million, from $70 million. In addition, management is raising its earnings per diluted share guidance for the full year 2005 to $0.87, from $0.62. The projected increase in earnings per diluted share is primarily attributable to better than expected third quarter 2005 results and a strong outlook for the fourth quarter 2005.
Conference Call
Cutera, Inc. will host a conference call on November 1, 2005, at 2:00 p.m. PST (5:00 p.m. EST) to discuss its third quarter 2005 results. The earnings call will be broadcast live over the internet hosted at the Investor Relations section of the Company’s website athttp://www.cutera.com and will be archived online within one hour of the completion of the conference call. In addition, you may call 800-811-8824. Participating in the call will be Kevin Connors, President and Chief Executive Officer, and Ron Santilli, Chief Financial Officer.
A telephonic playback will be available from 5:00 p.m. PST on November 1, 2005 through 11:59 p.m. PST on November 15, 2005 by calling 888-203-1112. To access this playback, please enter pass code 2547083.
About Cutera, Inc.
Brisbane, California -based Cutera is a leading provider of laser and other light-based aesthetic systems to the professional aesthetic market. Since 1998, Cutera has been developing innovative, easy-to-use products that enable dermatologists, plastic surgeons, gynecologists, primary care physicians and other qualified practitioners to offer safe, effective and non-invasive aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visitwww.cutera.com
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera’s ability to broaden its product offerings and its target market, to expand its sales force, to generate increased demand and to increase its market share, as well as Cutera’s financial guidance for the fourth quarter and fiscal year 2005, are forward-looking statements within the meaning of the Safe Harbor. Forward-Looking statements are based on management’s current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera’s actual results to differ materially from the statements contained herein. Cutera’s third quarter financial results, as discussed in this release, are
preliminary and unaudited, and subject to adjustment. Estimates for the fourth quarter of 2005 financial results are subject to a number of assumptions regarding the future operation of our business. Further information on potential risk factors that could affect Cutera’s business and its financial results are detailed in its most recent 10-K and 10-Q as filed with the Securities and Exchange Commission. Undue reliance should not be placed on forward–looking statements, especially guidance on future financial performance, which speaks only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
—Financial Tables Follow—
CUTERA, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
September 30, 2005 | December 31, 2004 | |||||||
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 4,728 | $ | 7,070 | ||||
Marketable investments | 77,488 | 59,200 | ||||||
Accounts receivable, net | 5,331 | 6,643 | ||||||
Inventory | 5,000 | 3,004 | ||||||
Deferred tax asset | 2,284 | 2,284 | ||||||
Other current assets | 1,909 | 878 | ||||||
Total current assets | 96,740 | 79,079 | ||||||
Property and equipment, net | 1,044 | 1,071 | ||||||
Intangibles, net | 502 | 399 | ||||||
Total assets | $ | 98,286 | $ | 80,549 | ||||
Liabilities and Stockholders’ Equity | ||||||||
Liabilities: | ||||||||
Accounts payable | $ | 1,625 | $ | 1,195 | ||||
Accrued liabilities | 8,553 | 8,194 | ||||||
Deferred revenue | 1,427 | 1,171 | ||||||
Total current liabilities | 11,605 | 10,560 | ||||||
Deferred rent | 984 | 648 | ||||||
Deferred revenue, net of current portion | 1,156 | 833 | ||||||
Non-current portion of deferred tax liability | 60 | 52 | ||||||
Total liabilities | 13,805 | 12,093 | ||||||
Stockholders’ equity: | ||||||||
Common stock | 12 | 11 | ||||||
Additional paid-in capital | 71,002 | 62,738 | ||||||
Deferred stock-based compensation | (2,417 | ) | (2,226 | ) | ||||
Retained earnings | 15,933 | 7,942 | ||||||
Other comprehensive loss | (49 | ) | (9 | ) | ||||
Total stockholders’ equity | 84,481 | 68,456 | ||||||
Total liabilities and stockholders’ equity | $ | 98,286 | $ | 80,549 | ||||
CUTERA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
2005 | 2004 | 2005 | 2004 | |||||||||||||
Net revenue | $ | 18,950 | $ | 12,703 | $ | 51,667 | $ | 36,548 | ||||||||
Cost of revenue(1) | 4,746 | 3,408 | 13,642 | 10,454 | ||||||||||||
Gross profit | 14,204 | 9,295 | 38,025 | 26,094 | ||||||||||||
Operating expenses: | ||||||||||||||||
Sales and marketing | 6,151 | 4,677 | 17,694 | 13,578 | ||||||||||||
Research and development | 1,275 | 979 | 3,692 | 2,985 | ||||||||||||
General and administrative | 1,621 | 2,171 | 5,819 | 6,151 | ||||||||||||
Amortization of stock-based compensation(2) | 433 | 317 | 1,100 | 954 | ||||||||||||
Total operating expenses | 9,480 | 8,144 | 28,305 | 23,668 | ||||||||||||
Income from operations | 4,724 | 1,151 | 9,720 | 2,426 | ||||||||||||
Interest and other income, net | 549 | 198 | 1,351 | 255 | ||||||||||||
Income before income taxes | 5,273 | 1,349 | 11,071 | 2,681 | ||||||||||||
Provision for income taxes | (1,472 | ) | (472 | ) | (3,080 | ) | (991 | ) | ||||||||
Net income | $ | 3,801 | $ | 877 | $ | 7,991 | $ | 1,690 | ||||||||
Net income available to common shareholders used in basic earnings per share earnings per share | $ | 3,801 | $ | 877 | $ | 7,991 | $ | 1,394 | ||||||||
Net income per share: | ||||||||||||||||
Basic | $ | 0.33 | $ | 0.08 | $ | 0.70 | $ | 0.18 | ||||||||
Diluted | $ | 0.27 | $ | 0.07 | $ | 0.58 | $ | 0.14 | ||||||||
Weighted-average number of shares used in per share calculations: | ||||||||||||||||
Basic | 11,661 | 10,729 | 11,369 | 7,863 | ||||||||||||
Diluted | 13,924 | 13,085 | 13,681 | 11,922 | ||||||||||||
(1) Cost of revenue includes amortization of stock-based compensation of: | $ | 40 | $ | 39 | $ | 102 | $ | 129 | ||||||||
(2) Amortization of stock-based compensation is attributable to the following operating expense categories: | ||||||||||||||||
Sales and marketing | 71 | 63 | 160 | 211 | ||||||||||||
Research and development | 59 | 105 | 240 | 309 | ||||||||||||
General and administrative | 303 | 149 | 700 | 434 | ||||||||||||
433 | 317 | 1,100 | 954 | |||||||||||||
Total amortization of stock-based compensation | $ | 473 | $ | 356 | $ | 1,202 | $ | 1,083 | ||||||||
CUTERA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Nine Months Ended September 30, | ||||||||
2005 | 2004 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 7,991 | $ | 1,690 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 503 | 380 | ||||||
Allowance for doubtful accounts | (296 | ) | 102 | |||||
Change in reserve for excess and obsolete inventory | 434 | 95 | ||||||
Stock-based compensation | 1,202 | 1,083 | ||||||
Change in deferred tax asset | 8 | (759 | ) | |||||
Tax benefits from stock based award activity | 3,125 | 182 | ||||||
Loss on disposal of assets | — | 104 | ||||||
Changes in assets and liabilities: | ||||||||
Accounts receivable | 1,608 | 1,172 | ||||||
Inventory | (2,430 | ) | (965 | ) | ||||
Other current assets | (1,031 | ) | (34 | ) | ||||
Accounts payable | 430 | 16 | ||||||
Accrued liabilities | 359 | 985 | ||||||
Deferred rent | 336 | 536 | ||||||
Deferred revenue | 579 | 714 | ||||||
Net cash provided by operating activities | 12,818 | 5,301 | ||||||
Cash flows from investing activities: | ||||||||
Acquisition of property and equipment | (414 | ) | (652 | ) | ||||
Purchase of intangibles | (165 | ) | — | |||||
Proceeds from sales of marketable investments | 18,294 | — | ||||||
Proceeds from maturities of marketable investments | 34,373 | — | ||||||
Purchase of short term investments, net | (70,995 | ) | (6,055 | ) | ||||
Change in restricted cash | — | 250 | ||||||
Net cash used in investing activities | (18,907 | ) | (6,457 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | 3,747 | 441 | ||||||
Proceeds from issuance of common stock, net | — | 46,336 | ||||||
Net cash provided by financing activities | 3,747 | 46,777 | ||||||
Net (decrease) / increase in cash and cash equivalents | (2,342 | ) | 45,621 | |||||
Cash and cash equivalents at beginning of period | 7,070 | 10,290 | ||||||
Cash and cash equivalents at end of period | $ | 4,728 | $ | 55,911 | ||||
Supplemental disclosure of cash flow information: | ||||||||
Change in deferred stock based compensation, net of terminations | $ | 1,393 | $ | (175 | ) | |||
Conversion of preferred stock to common stock | $ | — | $ | 7,372 |